Literature DB >> 3597687

Race, socioeconomic status, and other prognostic factors for survival from colo-rectal cancer.

H Dayal, L Polissar, C Y Yang, S Dahlberg.   

Abstract

Survival data on colo-rectal cancer patients from eleven comprehensive cancer centers were analyzed to examine the effect of race, socioeconomic status and other factors on the probability of survival. Complete data on variables of interest were available for 3617 colon cancer patients (2545 Caucasians and 1072 Blacks) and 1528 rectal cancer patients (1179 Caucasians and 349 Blacks). No significant difference was observed between the races with respect to either the follow-up time or the censoring pattern. For each site, Caucasian patients had a lower risk of death at any time point compared to Black patients, and this difference was maintained within categories of disease stage, sex, age and SES. The race effect was statistically significant in all multivariate models. Moreover, only race was significant in models that considered both race and SES. For either cancer, the racial difference in survival was most prominent for localized disease.

Entities:  

Mesh:

Year:  1987        PMID: 3597687     DOI: 10.1016/0021-9681(87)90185-8

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  19 in total

1.  Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma.

Authors:  Dominik Alexander; Chakrapani Chatla; Ellen Funkhouser; Sreelatha Meleth; William E Grizzle; Upender Manne
Journal:  Cancer       Date:  2004-07-01       Impact factor: 6.860

2.  Surgical outcomes research based on administrative data: inferior or complementary to prospective randomized clinical trials?

Authors:  Ulrich Guller
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

3.  The frequency of early repeat tests after colonoscopy in elderly medicare recipients.

Authors:  Robert J Richards; Stephen Crystal
Journal:  Dig Dis Sci       Date:  2009-02-25       Impact factor: 3.199

4.  High-grade tumor differentiation is an indicator of poor prognosis in African Americans with colonic adenocarcinomas.

Authors:  Dominik Alexander; Nirag Jhala; Chakrapani Chatla; Jon Steinhauer; Ellen Funkhouser; Christopher S Coffey; William E Grizzle; Upender Manne
Journal:  Cancer       Date:  2005-05-15       Impact factor: 6.860

5.  Increasing Disparity in Colorectal Cancer Incidence and Mortality Among African Americans and Whites: A State's Experience.

Authors:  Noelle K Loconte; Amy Williamson; Arlene Gayle; Jennifer Weiss; Ticiana Leal; Jeremy Cetnar; Tabraiz Mohammed; Amye Tevaarwerk; Nathan Jones
Journal:  J Gastrointest Oncol       Date:  2011

6.  Measuring social class differences in cancer patient survival: is it necessary to control for social class differences in general population mortality? A Finnish population-based study.

Authors:  P W Dickman; A Auvinen; E T Voutilainen; T Hakulinen
Journal:  J Epidemiol Community Health       Date:  1998-11       Impact factor: 3.710

7.  Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries.

Authors:  G S Cooper; Z Yuan; C S Landefeld; A A Rimm
Journal:  Am J Public Health       Date:  1996-04       Impact factor: 9.308

Review 8.  Cancer patient survival by socioeconomic status in seven countries: a review for six common cancer sites [corrected].

Authors:  C T Schrijvers; J P Mackenbach
Journal:  J Epidemiol Community Health       Date:  1994-10       Impact factor: 3.710

9.  Racial differences in dietary changes and quality of life after a colorectal cancer diagnosis: a follow-up of the Study of Outcomes in Colorectal Cancer Survivors cohort.

Authors:  Cari M Lewis; W Asher Wolf; Pengcheng Xun; Robert S Sandler; Ka He
Journal:  Am J Clin Nutr       Date:  2016-04-20       Impact factor: 7.045

10.  Racial differences in use of colonoscopy, sigmoidoscopy, and barium enema in Medicare beneficiaries.

Authors:  Robert J Richards; Dean M Reker
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.